A top Wall Street firm is getting more optimistic on Twitter’s prospects. J.P. Morgan raised its price target to $50 from $39 for the social media company’s shares, citing improving conversations with advertisers. “We are raising our estimates on TWTR shares as we believe advertising momentum is strengthening, particularly among large marketers,” analyst Doug Anmuth
0 Comments
J.P. Morgan added Weight Watchers to the firm’s list of “overweight” stocks, saying the weight loss company is poised for “outsized” growth as it looks to add more big-name celebrities through its partnership with Oprah Winfrey. “Management stabilized the trajectory … by revamping its points program, significantly improving the mobile platform, and recruiting pivotal social
0 Comments
Retirement planning today is not what it used to be. Decades ago, retirees could simply shift their investments into fixed income, which historically paid higher rates of interest. Today, those same investments likely pay very little. Complicating matters further, we’re all living much longer, so we need to be careful we don’t outlive our money.
0 Comments
President Donald Trump‘s agreement with North Korean leader Kim Jong Un allows the market to focus on more pressing issues such as the Federal Reserve‘s policy meeting, economist Mohamed El-Erian told CNBC on Tuesday. “Look for markets to say, ‘Great, that’s a first, good constructive step with what happened in Singapore,'” Allianz’s chief economic advisor
0 Comments
Uber and Lyft each want to be the all-encompassing transportation platform of the future, shepherding people around the world through whatever means is best suited — and the ride-hailing firms are getting close. Uber CEO Dara Khosrowshahi told CNBC last week the company wanted to be “the A-to-B platform for transportation.” Khosrowshahi said he wants
0 Comments
New technologies for diabetes treatment are becoming essential for those who suffer from the disease, according to J.P. Morgan, and that could make companies such as Dexcom compelling investment opportunities. “The diabetes space is currently experiencing its biggest technological wave of innovation from glucose measurement (continuous glucose monitoring) to insulin dosing (insulin pumps),” analyst Robbie
0 Comments